Blinded Study Medication - Condition 1-Johns Hopkins University

This is a placeholder name for an undisclosed, FDA-approved medication used in the clinical trial "Measuring Acute Drug Demand in Humans II" (NCT05443607), conducted by Johns Hopkins University. The study evaluates the acute demand, mood, pain, and cognitive effects of various substances in healthy volunteers. To maintain the integrity of the double-blind study design, the specific identity of the medication—which may be a prescription stimulant, cannabinoid, benzodiazepine, opioid, sleep medication, or over-the-counter drug—is not revealed in the clinical trial record. The medication is administered orally, and detailed information regarding the specific drug condition is intended to be added to the record only upon completion of the study.